RxDoctor Payments DataLook up a doctor →

Clifford Garvin, MD

Family Practice · Denison, TXNPI 1528095502

Payments from drug & device makers

$5,113in general payments, 2019–2025

Across 313 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$872
  • Pfizer$619
  • Otsuka America Pharmaceutical, Inc.$431
  • GSK$344
  • Johnson & Johnson$326
  • Novo Nordisk$225
  • plus $2K from 44 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)64$872
Pfizer34$619
Otsuka America Pharmaceutical, Inc.23$431
GSK21$344
Johnson & Johnson21$326
Novo Nordisk17$225
Merck17$214
Lilly USA, LLC11$192
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)10$188
AstraZeneca11$167
Avanir Pharmaceuticals, Inc.7$104
Novartis5$91
Sumitomo Pharma America, Inc.4$88
Phathom Pharmaceuticals, Inc.5$86
Takeda Pharmaceuticals U.S.A., Inc.5$75
Eisai Inc.4$68
Mylan Specialty L.p.3$66
Astellas Pharma US Inc3$58
Teva Pharmaceuticals USA, Inc.2$54
Kyowa Kirin, Inc.2$51
Corcept Therapeutics2$48
Corium, LLC2$48
Nestle Healthcare Nutrition Inc.2$44
Biogen2$40
Ardelyx, Inc.2$38
Xeris Pharmaceuticals, Inc.2$38
Avion Pharmaceuticals2$35
Abbott2$33
Sun Pharmaceutical Industries Inc.2$33
Scilex Pharmaceuticals Inc.2$33
Sanofi-aventis U.S. LLC2$31
Idorsia Pharmaceuticals US Inc2$30
Ultragenyx Pharmaceutical Inc.2$30
Lundbeck LLC2$28
Vanda Pharmaceuticals Inc.1$26
UCB, Inc.1$24
Dexcom, Inc.1$22
Viatris Specialty LLC1$20
Paratek Pharmaceuticals, Inc.1$19
Bayer1$19
Neurelis, Inc.1$18
Amgen1$18
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$17
Exact Sciences1$17
SK Life Science, Inc.1$16
Axsome Therapeutics, Inc.1$16
Sunovion Pharmaceuticals Inc.1$15
Otsuka Pharmaceutical Development & Commercialization, Inc.1$14
Kowa Pharmaceuticals America, Inc.1$14
Ironwood Pharmaceuticals, Inc1$11

How this compares

$5,113 in reported general payments places this provider in the 95th percentile of 646 family practice providers in Texas.

See all family practice providers in Texas →

Medicare billing

Part B allowed, 2024
$601,661
Medicare patients
840
Services billed
8,028

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family practice in Denison

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →